Sildenafil
Product Images NDC 68788-7218

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68788-7218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sildenafil Fig1)

The text provides a table representing the change in sitting systolic blood pressure in healthy volunteers over time after taking 100mg of Sildenafil or a placebo. The table includes blood pressure measurements in mmHg for pre-dose and different time intervals post-dose. No further information is available.*

FDA Label Image

Sildenafil Tablets 100mg Aurobindo (Sildenafil Fig10)

This is a cautionary label for Sildenafil Tablets 100mg, a generic drug for Viagra that contains Sildenafil citrate USP in the package of 52 tablets. Federal law prohibits transferring the drug to any person other than the patient for whom it was prescribed. The product is from Mfg' Aurobindo Pharma Limited with an expiration date, lot number, and batch number. The rest of the information is not available.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

The figure shows the mean standing systolic blood pressure change from baseline at different times postdose for two treatment groups: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The change in SBP ranges from 0 to 30 mmHg.*

FDA Label Image

Figure 3 (Sildenafil Fig3)

This is a chart depicting the mean standing systolic blood pressure change from baseline over time post-dose for two different treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The x-axis represents time post-dose in hours and the y-axis represents the mean standing systolic blood pressure change from baseline. No further context or information is available.*

FDA Label Image

Figure 4 (Sildenafil Fig4)

FDA Label Image

Figure 5 (Sildenafil Fig5)

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

This is a graph depicting the effect of Sildenafil and placebo on the maintenance of an erection by the baseline score. The graph shows the percentage of patients at the endpoint and their respective scores. The baseline scores range from 0 to 80, with 10-point increments.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

FDA Label Image

Structure (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.